» Articles » PMID: 27905214

The Association of Plasma Oxidative Status and Inflammation with the Development of Atrial Fibrillation in Patients Presenting with ST Elevation Myocardial Infarction

Overview
Publisher Informa Healthcare
Specialty Science
Date 2016 Dec 2
PMID 27905214
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST elevation myocardial infarction (STEMI). Oxidative stress and inflammation may cause structural and electrical remodeling in the atria making these critical processes in the pathology of AF. In this study, we aimed to evaluate the association between total oxidative status (TOS), total antioxidative capacity (TAC) and high-sensitivity C-reactive protein (hs-CRP) in the development of AF in patients presenting with STEMI. This prospective cohort study consisted of 346 patients with STEMI. Serum TAC and TOS were assessed by Erel's method. Patients were divided into two groups: those with and those without AF. Predictors of AF were determined by multivariate regression analysis. In the present study, 9.5% of patients developed AF. In the patients with AF, plasma TOS and oxidative stress index (OSI) values were significantly higher and plasma TAC levels were significantly lower compared to those without AF (p = .003, p = .002, p < .0001, respectively). Multivariate regression analysis results showed that, female gender (Odds ratio [OR] = 3.07; 95% Confidence Interval [CI] = 1.26-7.47; p = .01), left atrial diameter (OR =1.28; 95% CI =1.12-1.47; p < .0001), hs-CRP (OR =1.02; 95% CI =1.00-1.03; p = .001) and OSI (OR =1.10; 95% CI =1.04-1.18; p = .001) were associated with the development of AF in patients presenting with STEMI. The main finding of this study is that oxidative stress and inflammation parameters were associated with the development of AF in patients presenting with STEMI. Other independent predictors of AF were female gender, left atrial diameter and hs-CRP.

Citing Articles

The bidirectional association between atrial fibrillation and myocardial infarction.

Frederiksen T, Dahm C, Preis S, Lin H, Trinquart L, Benjamin E Nat Rev Cardiol. 2023; 20(9):631-644.

PMID: 37069297 PMC: 11380523. DOI: 10.1038/s41569-023-00857-3.


TRIM21 deficiency protects against atrial inflammation and remodeling post myocardial infarction by attenuating oxidative stress.

Liu X, Zhang W, Luo J, Shi W, Zhang X, Li Z Redox Biol. 2023; 62:102679.

PMID: 36996623 PMC: 10074251. DOI: 10.1016/j.redox.2023.102679.


The association between systemic inflammatory response index and new-onset atrial fibrillation in patients with ST-elevated myocardial infarction treated with percutaneous coronary intervention.

Wang J, Hu S, Liang C, Ling Y BMC Cardiovasc Disord. 2022; 22(1):525.

PMID: 36474135 PMC: 9724303. DOI: 10.1186/s12872-022-02989-9.


Predictive value of oxidative, antioxidative, and inflammatory status for left ventricular systolic recovery after percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Aksoy F, Bas H, Bagci A, Savas H, Ozaydin M Rev Assoc Med Bras (1992). 2022; 68(10):1369-1375.

PMID: 36417638 PMC: 9683925. DOI: 10.1590/1806-9282.20220300.


Molecular mechanisms of sacubitril/valsartan in cardiac remodeling.

Mustafa N, Jalil J, Zainalabidin S, Saleh M, Asmadi A, Kamisah Y Front Pharmacol. 2022; 13:892460.

PMID: 36003518 PMC: 9393311. DOI: 10.3389/fphar.2022.892460.